person

Silvia Maria T.

Country
Italy
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
4
Sites with multiple studies

Has run more than one trial at 4 of 140 partner sites.

Specializations

Hematological Disorders

This investigator specializes in the study of congenital Thrombotic Thrombocytopenic Purpura (cTTP), a rare inherited blood disorder affecting the blood clotting system. Their research focuses on evaluating therapeutic approaches for managing this challenging condition.

  • Blood Coagulation Disorders
  • Rare Hematological Diseases
  • Inherited Blood Disorders

The investigator's work encompasses both prophylactic and on-demand treatment strategies for patients with blood disorders.

Clinical Safety Assessment

The investigator concentrates on evaluating the long-term safety and tolerability of novel therapeutic approaches. Their expertise includes monitoring treatment-emergent adverse events and serious adverse events in clinical settings.

  • Treatment Safety Evaluation
  • Long-term Patient Monitoring
  • Adverse Event Assessment

Their research methodology incorporates comprehensive safety monitoring protocols for therapeutic interventions.

Therapeutic Innovation

The investigator is involved in studying innovative treatment approaches for rare hematological conditions. Their work includes evaluation of recombinant proteins and novel therapeutic agents for blood disorders.

  • Novel Therapeutic Development
  • Protein-based Treatments
  • Rare Disease Therapeutics

Their research contributes to advancing treatment options for patients with rare hematological disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.